Skip to content

Coeur Mining

US · CDE #988 by market cap Listed 1970
10.68 -0.86 -7.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:57

Recent news

  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of the Company\'s Active Pharmaceutical Ingredient by the CDE Review
    SZSI · 2026/6/18
  • Rating change
    Roth MKM Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $21
    Market Newswire · 2026/7/17
  • Rating change
    Roth MKM Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/10/29
  • Rating change
    Scotiabank Maintains Coeur Mining(CDE.US) With Buy Rating, Maintains Target Price $26.5
    Market Newswire · 2026/11/5
  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of the Company\'s Active Pharmaceutical Ingredient by the CDE Review
    SZSI · 2026/6/3
  • Rating change
    A Quick Look at Today's Ratings for Coeur Mining(CDE.US), With a Forecast Between $18 to $26.5
    Market Newswire · 2026/8/7
  • Rating change
    BMO Capital Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $26
    Market Newswire · 2026/8/6
  • CIBC Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $27
    Market Newswire · 2026/11/6
  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of Its Wholly-Owned Subsidiary's Active Pharmaceutical Ingredient by the CDE Review
    SZSI · 2026/10/30
  • Rating change
    Scotiabank Maintains Coeur Mining(CDE.US) With Buy Rating, Raises Target Price to $28.5
    Market Newswire · 2026/7/15
  • Roth MKM Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $16
    Market Newswire · 2026/11/6
  • Scotiabank Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $23.5
    Market Newswire · 2026/11/9
  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of Its Wholly-Owned Subsidiary's Active Pharmaceutical Ingredient by the CDE Review
    SZSI · 2026/9/5
  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of the Company\'s Active Pharmaceutical Ingredient by the CDE Review
    SZSI · 2026/7/14
  • Rating change
    ATB Cormark Capital Markets Downgrades Coeur Mining(CDE.US) to Hold Rating, Cuts Target Price to $18
    Market Newswire · 2026/8/7
  • Rating change
    Scotiabank Initiates Coeur Mining(CDE.US) With Buy Rating, Announces Target Price $28.5
    Market Newswire · 2026/7/23
  • Rating change
    Scotiabank Initiates Coeur Mining(CDE.US) With Buy Rating, Announces Target Price $27.5
    Market Newswire · 2026/6/12
  • Jiuyuan Gene is surging after the CDE officially accepted its IND application for JY54-2 injection, which targets two indications.
    Zhitong Finance · 2026/11/19
  • RBC Capital Initiates Coeur Mining(CDE.US) With Buy Rating, Announces Target Price $23
    Market Newswire · 2026/11/10
  • Rating change
    RBC Capital Maintains Coeur Mining(CDE.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2026/10/14
  • Rating change
    RBC Capital Maintains Coeur Mining(CDE.US) With Buy Rating, Cuts Target Price to $23
    Market Newswire · 2026/6/4
  • Earnings Flash (CDE) Coeur Mining, Inc. Posts Q3 Adjusted EPS $0.10 per Share, Vs. FactSet Est of $0.14
    MT Newswires · 2026/11/5
  • Earnings Flash (CDE) Coeur Mining, Inc. Reports Q3 Revenue $983.6M, Vs. FactSet Est of $1.14B
    MT Newswires · 2026/11/5
  • Company notice
    Tianyu Co., Ltd.: Announcement Regarding the Approval of Active Pharmaceutical Ingredients by the CDE
    SZSI · 2026/5/8
  • Scotiabank Maintains Coeur Mining(CDE.US) With Buy Rating, Maintains Target Price $26.5
    Market Newswire · 2026/9/23

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:57:15 · For reference only, not investment advice and not tailored to your situation.

Coeur Mining discussion 0 comments

Add a comment